Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 7:26 pm Purchase | 13G | EXAGEN INC XGN | Stonepine Capital Management LLC | 858,567 5.3% | 25,030 (+3.00%) | View |
| 2022-02-11 7:06 pm Purchase | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 9,754,935 9.99% | 1,606,515 (+19.72%) | View |
| 2022-02-11 7:03 pm Purchase | 13G | APOLLO ENDOSURGERY INC APEN | Stonepine Capital Management LLC | 2,655,129 6.5% | 51,649 (+1.98%) | View |
| 2022-02-11 6:45 pm Purchase | 13G | REZOLUTE INC RZLT | Stonepine Capital Management LLC | 808,405 5.2% | 19,079 (+2.42%) | View |
| 2022-02-11 6:24 pm Purchase | 13G | CONFORMIS INC CFMS | Stonepine Capital Management LLC | 14,768,823 7.9% | 5,606,952 (+61.20%) | View |
| 2022-02-11 6:22 pm Sale | 13G | YUMANITY THERAPEUTICS INC YMTX | Stonepine Capital Management LLC | 0 0% | -643,620 (Position Closed) | View |
| 2022-02-11 5:55 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 0 0% | -2,144,812 (Position Closed) | View |
| 2022-02-11 5:47 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | Stonepine Capital Management LLC | 4,006,185 5.9% | 506,185 (+14.46%) | View |
| 2022-02-11 5:45 pm Sale | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 385,650 1.6% | -1,145,000 (-74.80%) | View |
| 2022-02-11 3:32 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Stonepine Capital Management LLC | 0 0% | -2,273,876 (Position Closed) | View |
| 2022-02-11 3:29 pm Sale | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 0 0% | -1,398,776 (Position Closed) | View |
| 2022-02-11 2:27 pm Purchase | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | Stonepine Capital Management LLC | 30,348,875 9.5% | 19,266,460 (+173.85%) | View |
| 2022-02-11 2:17 pm Purchase | 13G | DIAMEDICA THERAPEUTI DMAC | Stonepine Capital Management LLC | 1,394,929 5.3% | 244,670 (+21.27%) | View |
| 2022-01-13 6:13 pm Purchase | 13G | XERIS BIOPHARMA HLDGS INC XERS | Stonepine Capital Management LLC | 6,491,099 5.2% | 6,491,099 (New Position) | View |
| 2021-12-30 12:26 pm Purchase | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management LLC | 9,972,877 5.1% | 9,972,877 (New Position) | View |
| 2021-12-23 5:34 pm Purchase | 13G | REZOLUTE INC RZLT | Stonepine Capital Management LLC | 789,326 5.1% | 789,326 (New Position) | View |
| 2021-12-23 5:33 pm Purchase | 13G | EXAGEN INC XGN | Stonepine Capital Management LLC | 833,537 5.2% | 833,537 (New Position) | View |
| 2021-11-19 4:55 pm Purchase | 13G | YUMANITY THERAPEUTICS INC YMTX | Stonepine Capital Management LLC | 643,620 6.2% | 643,620 (New Position) | View |
| 2021-08-09 4:06 pm Sale | 13G | CHIASMA INC CHMA | Stonepine Capital Management LLC | 0 0% | -6,770,000 (Position Closed) | View |
| 2021-07-09 5:06 pm Purchase | 13G | STRONGBRIDGE BIOPHARMA PLC SHS SBBP | Stonepine Capital Management LLC | 3,566,964 5.3% | 3,566,964 (New Position) | View |